Structural basis of metallo-β-lactamase resistance to taniborbactam

• Published in: Antimicrobial agents and chemotherapy 2024-02, Vol.68 (2), p.e0116823
• Main Authors: Drusin, Salvador I, Le Terrier, Christophe, Poirel, Laurent, Bonomo, Robert A, Vila, Alejandro J, Moreno, Diego M
• Format: Article
• Language: English
• Subjects: Anti-Bacterial Agents - pharmacology; beta-Lactam Resistance; beta-Lactamase Inhibitors - pharmacology; beta-Lactamases - metabolism; Borinic Acids - pharmacology; Carboxylic Acids; Editor’s Pick; Mechanisms of Resistance; Microbial Sensitivity Tests; Structural Biology
• ISSN: 0066-4804; 1098-6596; 1098-6596
• DOI: 10.1128/aac.01168-23

The design of inhibitors against metallo-β-lactamases (MBLs), the largest family of carbapenemases, has been a strategic goal in designing novel antimicrobial therapies. In this regard, the development of bicyclic boronates, such as taniborbactam (TAN) and xeruborbactam, is a major achievement that may help in overcoming the threat of MBL-producing and carbapenem-resistant Gram-negative pathogens. Of concern, a recent report has shown that New Delhi MBL-9 (NDM-9) escapes the inhibitory action of TAN by a single amino acid substitution with respect to New Delhi MBL-1 (NDM-1), the most widely disseminated MBL. Here, we report a docking and computational analysis that identifies that "escape variants" against TAN can arise by disruption of the electrostatic interaction of negative charges in the active site loops of MBLs with the N-(2-aminoethyl)cyclohexylamine side chain of TAN. These changes result in non-productive binding modes of TAN that preclude reaction with the MBLs, a phenomenon that is not restricted to NDM-9. This analysis demonstrates that single amino acid substitutions in non-essential residues in MBL loops can unexpectedly elicit resistance to TAN.